Latest

First blood-based in vitro diagnostic test to receive FDA clearance to help identify patients with amyloid pathology associated with Alzheimer’s disease

New test provides less invasive option, reduces reliance on PET scans, and increases diagnosis accessibility

North American and African clinical trials led by Scripps Research, IAVI, and additional collaborators across the US and Africa mark progress toward an effective HIV vaccine

In a proof-of-concept study, the test detected five key biomarkers of Alzheimer’s disease—more than current commercially available blood tests can measure

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

Even small tissue samples can yield additional insights into a tumor’s biology, immune interactions, and molecular pathways

Explore studies, workflows, and strategies that use rapid, point-of-care tools to overcome barriers to testing and treatment access for syphilis, HIV, and HCV

Researchers estimated about 8,500 tons of antibiotics end up in river systems each year after passing through the human body and wastewater systems

The College of Nursing and Innovation’s Center for Rural Health and Nursing launches cutting-edge unit to tackle workforce and training challenges

CMO Eric E. Walk, MD, FCAP, shares insights about digital and AI pathology implementation in medical laboratories

Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals, and improved drug safety

The FY2026 budget proposal includes devastating cuts to NIH of $18 billion, which would result in a nearly 40 percent cut in NIH’s budget for lifesaving research

Prior to the MSDA Test, disease management in MS relied primarily on clinical assessments and MRI

As clinical trial sponsors aim to reduce patient burden and improve engagement, point-of-care testing offers practical advantages

Measles is resurging in 2025 as falling vaccination rates and misinformation fuel a growing global health threat